Federal judge blocks Colorado from enforcing price cap on arthritis drug Enbrel during lawsuit
By
Meg Wingerter
10h ago· 5 min readenNews
Summary
A federal judge ruled that Colorado cannot cap the price of the arthritis drug Enbrel while a lawsuit from manufacturer Amgen proceeds. The Colorado Prescription Drug Affordability Review Board had declared Enbrel unaffordable in 2024 and set an upper payment limit of about $31,000 per year. Amgen sued to block the price ceiling, and the court granted a preliminary injunction preventing enforcement of the cap during the litigation.
Source
bskyFederal judge blocks Colorado from enforcing price cap on arthritis drug Enbrel during lawsuitdenverpost.comKey quotes
· 3 pulledColorado can't cap the price of arthritis medication Enbrel while a lawsuit challenging the state's drug affordability board's action plays out, a federal judge ruled last week.
In 2024, the Colorado Prescription Drug Affordability Review Board declared Enbrel unaffordable, and last year it set an 'upper payment limit' of about $31,000 per year.
Amgen, which owns Enbrel, sued the state in November, seeking to block the price ceiling.
In 2024, the Colorado Prescription Drug Affordability Review Board declared Enbrel unaffordable, and last year it set an “upper payment limit” of about $31,000 per year.
You might also wanna read
STAT+: U.S. judge blocks Colorado’s first-of-its-kind price cap on an Amgen drug
STAT·5d ago
STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and more
STAT·5d ago
FTC Takes Action to Protect Americans from Higher Drug Costs in Aurobindo, Lannett Deal
bulkorder.ftc.gov·19d ago
Prescription Drug Miebo Costs $800 in U.S. vs. $20 Over-the-Counter in Europe
The article reveals stark differences in drug pricing and accessibility between the U.S. and Europe, using Miebo (EvoTears) as a case study.
statnews.com·7mo agoState Weighs Tougher Staffing Rules Amid Rising Deficiencies as Medicaid Rates Are Cut
skillednursingnews.com·1d ago
Drugmakers Plan Price Increases on 350+ Medications Despite Government Pressure
Drugmakers plan to raise U.S. prices on at least 350 branded medications in 2026, including COVID, RSV, and shingles vaccines, as well as ca
reuters.com·6mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.